Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Wagner

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Disease Markers|October 5, 2002
Overview of biomarkers and surrogate endpoints in drug developmentJohn A Wagner
Clinical Pharmacology and Therapeutics|November 23, 2019
The Future of Translational Medicine: Accelerating Open ConvergenceJohn A Wagner
Annual Review of Pharmacology and Toxicology|October 17, 2007
Strategic approach to fit-for-purpose biomarkers in drug developmentJohn A Wagner
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Early clinical development of pharmaceuticals for type 2 diabetes mellitus: from preclinical models to human investigationJohn A Wagner
Biomarkers in Medicine|November 23, 2011
Open mind, open collaborationJohn A Wagner
Psychological Reports|October 29, 2025
Evidence of the File Drawer/Publication Bias Problem in Organization Research: An Affirmative Replication of Dalton, Aguinis, Dalton, Bosco, and Pierce (2012)John A Wagner
Psychological Reports|June 6, 2022
Significance of the Ontological/Utilitarian Distinction Among Measures of Individualism and CollectivismJohn A Wagner
Clinical Pharmacology and Therapeutics|December 7, 2017
Patient-Centered Reverse TranslationJohn A Wagner
Biomarkers in Medicine|December 8, 2010
Innovations driving biomarker evaluation and useJohn A Wagner
Diabetes Technology & Therapeutics|June 25, 2002
Physiological and therapeutic roles of peroxisome proliferator-activated receptorsJoel Berger, John A Wagner
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Disease Markers|October 5, 2002
Overview of biomarkers and surrogate endpoints in drug developmentJohn A Wagner
Clinical Pharmacology and Therapeutics|November 23, 2019
The Future of Translational Medicine: Accelerating Open ConvergenceJohn A Wagner
Annual Review of Pharmacology and Toxicology|October 17, 2007
Strategic approach to fit-for-purpose biomarkers in drug developmentJohn A Wagner
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Early clinical development of pharmaceuticals for type 2 diabetes mellitus: from preclinical models to human investigationJohn A Wagner
Biomarkers in Medicine|November 23, 2011
Open mind, open collaborationJohn A Wagner
Psychological Reports|October 29, 2025
Evidence of the File Drawer/Publication Bias Problem in Organization Research: An Affirmative Replication of Dalton, Aguinis, Dalton, Bosco, and Pierce (2012)John A Wagner
Psychological Reports|June 6, 2022
Significance of the Ontological/Utilitarian Distinction Among Measures of Individualism and CollectivismJohn A Wagner
Clinical Pharmacology and Therapeutics|December 7, 2017
Patient-Centered Reverse TranslationJohn A Wagner
Biomarkers in Medicine|December 8, 2010
Innovations driving biomarker evaluation and useJohn A Wagner
Diabetes Technology & Therapeutics|June 25, 2002
Physiological and therapeutic roles of peroxisome proliferator-activated receptorsJoel Berger, John A Wagner
Pageof 20